– July 1, 2003
July 1, 2003
View Issues
-
Preserving Ovarian Function in Cancer Survivors
There are increasing numbers of women who have been cured of cancer but have residual endocrine and reproductive ovarian failure. In the current report, a novel approach for reconstituting ovarian function in selected patients is presented. -
Meta-Analysis Indicates Value of Neoadjuvant Chemotherapy for Invasive Bladder Cancer
The value of neoadjuvant chemotherapy for invasive bladder cancer had not been definitively established, possibly because clinical trials have been of insufficient size to demonstrate efficacy. -
Adjuvant Bestatin Provides Survival Benefit for Stage I Squamous Cell Lung Cancer
In a multicenter trial from Japan, Bestatin, an aminopeptidase inhibitor, was shown to enhance survival in patients with stage I sqaumous cell carcinoma of the lung. -
Surgery vs Radiotherapy for Solitary Brain Metastases
There have been no randomized trials comparing surgery and radiotherapy for solitary brain metastases, nor are there well-defined guidelines for the management of these patients. -
Hormonal Contraception and Cervical Cancer
An increased risk of cervical cancer is associated with long durations of use of hormonal contraceptives. -
Drug Treatments to Prevent Breast Cancer
Only tamoxifen has enough evidence to recommend it for the prevention of breast cancer, and its use is limited to very high-risk women with a low risk of side effects.